Neurology 1310 - Neurology Alert - Oct 01, 2009

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
Michael Rubin, MD
Professor of Clinical Neurology
Weill Cornell Medical College

Author
Melissa J. Nirenberg, MD, PhD
Assistant Professor, Neurology and Neuroscience
Weill Cornell Medical College

Bruce T. Volpe, MD
Professor of Neurology and Neuroscience
Department of Neurology
Weill Cornell Medical College and the
Burke Rehabilitation Hospital.

Shefali Karkare, MD

Fellow, Division of Pediatric Neurology
Weill Medical College of Cornell University

Steven Weinstein, MD

Director, Pediatric Comprehensive Epilepsy Program
Weill Cornell Medical School
New York Presbyterian Hospital

Michael Lin, MD
Assistant Professor of Neurology and Neuroscience
Weill Medical College of Cornell University

John J. Caronna, MD
Professor of Clinical Neurology
Weill Cornell Medical College

Subjects:

  • Pesticides and Parkinson's Disease
  • Rituximab for Neuropathy with IgM Monoclonal Gammopathy
  • TMS as an Adjunct to Rehabilitation After Stroke: A Potential New Treatment
  • Anti-N-methyl-D-aspartate Receptor Encephalitis in Children and Adolescents
  • Value of CSF Aß/tau Profiles in Subjective and Mild Cognitive Impairment
  • One Hand Clapping

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert’s physician editor, Matthew Fink, MD, assistant editor Michael Rubin, MD, FRCP(C), authors Shefali Karkare, MD, Steven Weinstein, MD, Michael Lin, MD, and John J. Caronna, MD report no consultant, stockholder, speaker’s bureau, research, or other relationships related to this field of study. Peer reviewer M. Flint Beal, MD, reports no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company having ties to this field of study. Author Melissa J. Nirenberg, MD, PhD reports that she has participated in consulting for Biovail and clinical research trials sponsored by Boehringer-Ingleheim. Author Bruce T. Volpe, MD reports that he receives grant/research support from Wyeth/ Pfizer.

Copyright 2009 AHC Media. All rights reserved.